App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Get App
Select Language
Subscription
Specials
Close Ad
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
9111.90
363.15 (4.15%)
SENSEX
31159.62
1265.66 (4.23%)

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

| BSE 1601.85 -13.95 (-0.86%) | |

BSE Live

Apr 09, 16:00
1601.85 -13.95 (-0.86%)
Volume
AVERAGE VOLUME
5-Day
35,753
10-Day
33,371
30-Day
35,248
88,344

  • Prev. Close

    1615.80

  • Open Price

    1700.00

1550.45

Today’s L/H

1714.50
844.20

52 Wk L/H

1821.00
1292.65

L/U Price Band

1938.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    1621.05
     Beta
    0.35

  • Market Depth (09 Apr 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    20 1598.15 1602.00 106
    199 1597.60 1604.40 199
    49 1596.80 1605.00 152
    25 1596.25 1605.20 49
    99 1596.20 1605.80 99
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Apr 09, 15:59
1602.75 -13.65 (-0.84%)
Volume
AVERAGE VOLUME
5-Day
1,438,753
10-Day
989,408
30-Day
649,783
1,862,314

  • Prev. Close

    1616.40

  • Open Price

    1724.00

1550.00

Today’s L/H

1724.00
844.65

52 Wk L/H

1825.00
1293.15

L/U Price Band

1939.65

  • Bid Price (Qty.)

    1602.75 (455)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    1623.29
     Beta
    0.34
  • DELIVERY AVERAGES
    3-Day
    42.20%
    5-Day
    45.49%
    8-Day
    47.80%
    Deliverables
    42.20%
  • SMA
    30
    1388.54
    50
    1352.68
    150
    1154.74
    200
    1102.51
    SMA
    1388.54
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
See Detail
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 1701.17 1799.58 1875.17 1625.58 1527.17 1451.58 1353.17
Fibonacci 1692.05 1733.12 1799.58 1625.58 1559.12 1518.05 1451.58
Camarilla 1618.70 1634.65 1650.60 1625.58 1586.80 1570.85 1554.90

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 1505.72
10 1406.18
20 1370.86
50 1352.68
100 1253.79
200 1102.51
Get Historical Prices
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 1479.47 1573.38 1690.62 1362.23 1268.32 1151.08 1057.17
Fibonacci 1442.89 1492.72 1573.38 1362.23 1281.57 1231.74 1151.08
Camarilla 1404.91 1424.26 1443.62 1362.23 1366.19 1346.84 1327.48

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 1609.50 1826.75 2031.50 1404.75 1187.50 982.75 765.50
Fibonacci 1565.95 1665.55 1826.75 1404.75 1243.55 1143.95 982.75
Camarilla 1430.93 1469.62 1508.30 1404.75 1353.57 1314.88 1276.20

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      20,239.71
    • P/E
      31.93
    • Book Value (Rs)
      248.25
    • Dividend (%)
      150.00
    • Market Lot
      1
    • Industry P/E
      33.70
    • EPS (TTM)
      50.19
    • P/C
      25.13
    • Price/Book
      6.45
    • Dividend Yield.(%)
      0.19
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      42.20
      5-Day
      45.49
      8-Day
      47.80
      38.79

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      20,239.71
    • P/E
      32.72
    • Book Value (Rs)
      248.35
    • Dividend (%)
      150.00
    • Market Lot
      1
    • Industry P/E
      33.70
    • EPS (TTM)
      48.98
    • P/C
      25.26
    • Price/Book
      6.45
    • Dividend Yield.(%)
      0.19
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      42.20
      5-Day
      45.49
      8-Day
      47.80
      38.79

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 87% BUY
  • 13% SELL
  • 0% HOLD
87%
of moneycontrol users recommend buying Ipca Labs

What's your call on Ipca Labs today?

Read 52 investor views

BUY SELL HOLD
POST

Action in Ipca Laboratories Ltd.

News & Videos

Cadila Healthcare says can ramp up HCQ capacity, vaccine to enter human testing in Q2FY20

Cadila Healthcare says can ramp up HCQ capacity, vaccine to enter human testing in Q2FY20

Business | Earnings | Management Interviews
View More

News across the web

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Apr 10, 09:15
1700.00 84.20 (5.21%)
High 1744.00
Low 1700.00
Prev. Close 1615.80

NSE

Apr 10, 09:15
1724.00 107.60 (6.66%)
High 1724.00
Low 1615.00
Prev. Close 1616.40

Financials

Income Statement

  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 1,139.07 1,212.56 1,011.01 833.81 947.59
Other Income 17.63 14.33 19.43 14.58 12.63
PBDIT 265.44 261.56 195.04 174.67 231.70
Net Profit 196.63 196.02 132.05 109.47 160.18
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results Financial Ratios
  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 1,212.86 1,283.90 1,078.19 879.61 1,006.14
Other Income 18.13 14.80 20.34 15.26 13.34
PBDIT 273.66 265.86 198.72 164.58 234.46
Net Profit 200.06 194.91 131.02 96.99 159.52
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results Financial Ratios

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 25.27 25.24
Networth 3,136.66 2,694.95
Total Debt 329.80 473.05
Net Block 1,740.10 1,854.61
Investments 322.24 215.63
Total Assets 3,466.46 3,168.00

Historical Prices

On
 Current Price %Gain / Loss
Open Price 959.90 1700.00
77.1
High Price 959.90 1714.50
78.61
Low Price 919.05 1550.45
68.7
Close Price 935.15 1615.80
72.79
Volume 9,049 88,344
876.28
On
 Current Price %Gain / Loss
Open Price 944.30 1724.00
82.57
High Price 944.30 1724.00
82.57
Low Price 917.35 1550.00
68.96
Close Price 936.15 1616.40
72.66
Volume 235,974 1,862,314
689.2
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 9111.90 363.15 4.15
SENSEX 31159.62 1265.66 4.23
NIFTY BANK 19913.60 967.10 5.10
NIFTY IT 12728.55 237.05 1.90
S&P BSE Smallcap 10293.75 314.03 3.15
View More
Index Price Change %Chg
Shanghai Composite (Apr 10) 2,800.75 -25.15 -0.89
KOSPI (Apr 10) 1,860.70 24.49 1.33
Nikkei 225 (Apr 10) 19,498.50 152.73 0.79
Taiwan Weighted (Apr 10) 10,157.61 38.18 0.38
SGX Nifty (Apr 10) 9,114.50 54.50 0.60
View More

CORPORATE ACTION

Date Agenda
Feb 12, 2020 Quarterly Results
Sep 26, 2019 Issue Of Warrants
Aug 13, 2019 Quarterly Results
May 29, 2019 Audited Results & Final Dividend
View More
Type Dividend% Ex-Dividend date
Interim 250.00 Feb 18, 2020
Final 150.00 Aug 06, 2019
Final 50.00 Aug 02, 2018
Final 50.00 Jul 27, 2017
Final 50.00 Jul 22, 2015
View More
Ratio Announcement Date Ex-Bonus
1:1 Oct 27, 2004 Jan 28, 2005
View More
Old FV New FV Ex-Split
10 2 Mar 22, 2010
View More
Ratio Premium Ex-Bonus
No Rights Information is available for Ipca Laboratories
View More
Date Agenda
- -
Mar 29, 2019 -
Aug 09, 2018 -
Aug 04, 2017 -
Aug 11, 2016 -
View More

Dividend Summary

For the year ending March 2019 Ipca Laboratories has declared an equity dividend of 150.00% amounting to Rs 3 per share. At the current share price of Rs 1602.75 this results in a dividend yield of 0.19%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2019 June 2019 December 2018 September 2018
Promoters 46.07 46.07 46.07 46.07
Pledged 0 0 0 0
FII/FPI 16.14 15.58 15.77 16.41
Total DII 26.89 27.64 28.08 27.42
Fin.Insts 0.04 0.03 0.02 0.02
Insurance Co 0.78 0 0 0
MF 21.52 22.25 23 22.11
Others DIIs 4.55 5.36 5.06 5.29
Others 10.9 10.7 10.09 10.09
Total 100 99.99 100.01 99.99

Mutual Funds Holding

More Fund Action in Ipca Labs

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Ipca Labs 1601.85 -0.86 1821.00 844.20 20239.71 3,633.15 454.91
Sun Pharma 455.20 4.25 479.60 315.20 109217.73 10,303.21 816.60
Divis Labs 2313.90 6.80 2418.45 1466.95 61426.77 4,879.66 1,332.65
Dr Reddys Labs 3618.15 -1.70 3810.00 2352.00 60123.55 10,625.50 1,277.30
Cipla 579.50 12.96 595.00 356.75 46721.34 12,374.01 1,888.41

COMPANY OVERVIEW

Ipca Laboratories Ltd is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. It is one of the world`s largest manufacturers and suppliers of over a dozen APIs. These are produced right from the basic stage at manufacturing facilities endorsed by the world`s most discerning drug regulatory authorities like US-FDA, UK-MHRA, EDQM-Europe, WHO-Geneva and many more.

COMPANY INFORMATION

  • Registered Office

    • Address

      48, Kandivli Industrial Estate, Kandivli (West),,

    • City

      Mumbai

    • State

      Maharashtra

    • Pin Code

      400067

    • Tel. No.

      022-66474444

    • Fax No.

      022-62105005

    • Email

      investors@ipca.com

    • Internet

      http://www.ipca.com

  • Registrars

  • Management

    • Name

      Designation

    • Premchand Godha

      Chairman & M.D & CEO

    • Ajit Kumar Jain

      Joint Managing Director & CFO

    • Pranay Godha

      Executive Director

    • Prashant Godha

      Executive Director

    • Anand T Kusre

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Ipca Laboratories Ltd.

Ipca Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524494 and the NSE with an NSE Code of IPCALAB.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Ipca Laboratories Stock Price | Ipca Labs Stock Quote | Ipca Labs Results | Ipca Labs News | View All Related Searches
Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.